reports
Annual report 2023 confirms positive trend
Annual report 2023 confirms positive trend Copenhagen, April 30, 2024 (GLOBE NEWSWIRE) -- Announcement no. 7-2024 The media tech company Hypefactors presents the annual report for 2023. Revenue for the period amounted to DKK 11.219M, compared to DKK 9.384M in 2022, corresponding to an increase of 20%. Earnings before interest, tax, depreciation, and amortization (EBTIDA) amounted to DKK 1.974m, compared to 0.333M in 2022, corresponding to an increase of 493%. Hypefactors reached an annual recurring revenue (ARR) of DKK 13.024M per December 31, 2023, (2022: 10.625M) which is an i...
Studio City International Holdings Limited Announces Unaudited First Q...
Studio City International Holdings Limited Announces Unaudited First Quarter 2024 Earnings MACAU, April 30, 2024 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today reported its unaudited financial results for the first quarter of 2024. Total operating revenues for the first quarter of 2024 were US$150.2 million, compared with total operating revenues of US$51.5 million in the first quarter of 2023. The change was primarily attributable to the continued recovery in ...
Intra-Cellular Therapies to Host First Quarter 2024 Financial Results ...
Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Tuesday, May 7, 2024, to provide a corporate update and discuss details of the Company's financial results for the quarter ended March 31, 2024. To attend the live...
Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine C...
Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers Antibody rise observed in lactating mothers and in their breast milk Long-term goal is to provide protection to infants through passive antibody transfer SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it has completed the topline analysis for the Phase 1 clinical trial evaluating Vaxart’s oral pill bivalent norovirus vaccine candidate. The trial was focused on lactating mothers. Antibodies to norovirus rose on averag...
Franklin Electric Reports First Quarter 2024 Results
Franklin Electric Reports First Quarter 2024 Results First Quarter 2024 Highlights Consolidated net sales of $460.9 million, a decrease of 5% to the prior yearDistribution net sales increased 3%, while Water Systems and Fueling Systems net sales decreased 7% and 15%, respectivelyOperating income was $47.9 million with operating margin of 10.4%GAAP fully diluted earnings per share (EPS) was $0.70 FORT WAYNE, Ind., April 30, 2024 (GLOBE NEWSWIRE) -- Franklin Electric Co., Inc. today announced its first quarter financial results for fiscal year 2024. First quarter 2024 net sales were $460...
Melco Announces Unaudited First Quarter 2024 Earnings
Melco Announces Unaudited First Quarter 2024 Earnings MACAU, April 30, 2024 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment Limited (Nasdaq: MLCO) (“Melco” or the “Company”), a developer, owner, and operator of integrated resort facilities in Asia and Europe, today reported its unaudited financial results for the first quarter of 2024. Total operating revenues for the first quarter of 2024 were US$1.11 billion, representing an increase of approximately 55% from US$716.5 million for the comparable period in 2023. The increase in total operating revenues was primarily attributable to the...
NICE Actimize Positioned #1 in the Inaugural 2024 Chartis Financial Cr...
HOBOKEN, N.J.--(BUSINESS WIRE)-- NICE Actimize, a NICE (NASDAQ: NICE) business, has been positioned as #1 in the inaugural Chartis Research Financial Crime and Compliance50 Report (FCC 50). Chartis Research, part of Infopro Digital, is a leading provider of research and analysis on the global market for risk technology. NICE Actimize also received a category award for its solution expertise in Anti-Money Laundering (AML)/Transaction Monitoring (TM); a core technology award for its offering in Case Management; and a market-specific capabilities award for Global Banking. The Chartis Research F...
Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7...
Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024 TAMPA, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its first quarter financial results after the close of the U.S. markets on Tuesday May 7, 2024. Following the release, the company will host a live conference call and webcast at 4:30 p.m. ET. To participate in the conference call, dial 1-800-715-9871 and provide the passcode 6363041. International callers may dial 1-646-307-1963 and use the same passcode. In addition, a live audio of the co...
The Chefs’ Warehouse, Inc. to Participate in the BMO Global Farm to Ma...
The Chefs’ Warehouse, Inc. to Participate in the BMO Global Farm to Market Conference RIDGEFIELD, Conn., April 30, 2024 (GLOBE NEWSWIRE) -- The Chefs’ Warehouse, Inc. (the “Company”) (Nasdaq: CHEF), a premier distributor of specialty food products in the United States, the Middle East and Canada, today announced that the Company will present at the BMO Global Farm to Market Conference in New York, NY on Wednesday, May 15, 2024. The presentation will begin at 2:45 p.m. ET. Investors and interested parties may listen to a webcast of the fireside chat by visiting the Company’s investor rela...
As Consumers’ Debt Burdens Rise, Government Agencies Have Opportunitie...
As Consumers’ Debt Burdens Rise, Government Agencies Have Opportunities to Better Assist Them with Key Services TransUnion analysis identifies three core groups of constituents and ways the public sector can provide differentiated support for each CHICAGO, April 30, 2024 (GLOBE NEWSWIRE) -- U.S. consumers’ median minimum monthly debt payments grew by 32% between 2020 and 2023 – surpassing the rate of inflation (18%) during the same time. As consumer debt obligations continue to rise, a new TransUnion (NYSE: TRU) public sector study explores ways government agencies can better assist the...
Sutro Biopharma Announces Initiation of Randomized Portion (Part 2) of...
Sutro Biopharma Announces Initiation of Randomized Portion (Part 2) of REFRαME-O1 Trial – Part 2 of REFRαME-O1, the registration-directed study of luvelta for patients with platinum-resistant ovarian cancer (PROC), is open for enrollment – – Planned 50 patients in Dose-Optimization (Part 1) of REFRαME-O1 have been enrolled and are in follow up – SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today a...
Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Di...
Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today announced that an abstract for eflornithine, an inhibitor of polyamine synthesis, has been accepted for an oral presentation at the Digestive Disease Week (DDW) conference, which will be held May 18-21, 2024. The work reflects the Company’s on-going collaboration with Vanderbilt Univers...
Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy...
Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024 NEW HOPE, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced it will host an in-person R&D day at the Lotte New York Palace Hotel on Tuesday, June 11, 2024 at 10:00 AM ET. To register, . The event will feature presentations by company management and key opinio...
Ultragenyx Announces Completion of Enrollment in Phase 3 Orbit and Cos...
Ultragenyx Announces Completion of Enrollment in Phase 3 Orbit and Cosmic Studies Evaluating Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta (OI) NOVATO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that all patients have been enrolled across the Phase 3 Orbit and Cosmic studies evaluating setrusumab (UX143) in pediatric and young adult patients with osteogenesis imperfecta (OI). The pivotal Phase 3 portion of the Orbit study has randomized 158 patients ages 5 to 25 years, and the Cosmic study has completed enroll...
Recce Pharmaceuticals Announces Safety Committee Approves High Dose of...
Recce Pharmaceuticals Announces Safety Committee Approves High Dose of 4,000mg in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis Independent Safety Committee approves increase of RECCE® 327 (R327) dose to 4,000mg intravenously (IV) over 30 minutes for six subjects, with dosing to start in near weeksR327 dosed at 3,000mg has successfully been tested at various infusion times (15, 20, 30, 45 minutes, and 1 hour)Minimum Inhibitory Concentration (MIC) activity identified among existing clinical samples, a dose optimization exercise for regulatory purposes SYDNEY, Aus...
Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, P...
Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion ROCKAWAY, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the results of its most recent Truvaga Plus consumer study conducted earlier this year. Based on a 30-day in-home use test by an independent third-party research firm, Truvaga Plus helped its users improve sleep, focus, stress, energy, and mood. 39 participants were instructed to use the Truvaga Plus pro...
Twin Disc Approves a Quarterly Cash Dividend
Twin Disc Approves a Quarterly Cash Dividend MILWAUKEE, April 30, 2024 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (NASDAQ: TWIN), today announced that the Board of Directors (the "Board") approved a regular quarterly cash dividend of $0.04 per share payable on June 3, 2024, to shareholders of record at the close of business on May 20, 2024. About Twin DiscTwin Disc, Inc. designs, manufactures and sells marine and heavy-duty off-highway power transmission equipment. Products offered include marine transmissions, azimuth drives, surface drives, propellers and boat management systems, as well as p...
Alignment Healthcare to Present at Two Investor Conferences in May 202...
Alignment Healthcare to Present at Two Investor Conferences in May 2024 ORANGE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that John Kao, founder and CEO, and Thomas Freeman, chief financial officer, will present at the following conferences: BofA Securities 2024 Health Care Conference on Thursday, May 16, at 8:40 a.m. PDTLeerink Partners Healthcare Crossroads Conference on Wednesday, May 29, at 10:40 a.m. CDT A webcast and replay of the presentations will be available on Alignment’s investor relations website at . About Alignm...
Auddia Announces Strategic Product Expansion With Cloud Based Artifici...
Auddia Announces Strategic Product Expansion With Cloud Based Artificial Intelligence and Natural Language Processing Offering Proprietary AI and NLP Technology Used for Audio Stream Processing and Content Detection Being Ported to the Cloud Cloud Infrastructure Brings Scale Required to Attract and Enable SaaS Partnerships With Largest Audio Broadcasting and Publishing Companies, Enabling More Rapid Distribution of Auddia’s Technology BOULDER, CO, April 30, 2024 (GLOBE NEWSWIRE) -- via – (NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia" or the "Company"), developer of a proprietary AI platform...
Gentherm Wins 2024 Automotive News PACE Innovation Partnership Award
Gentherm Wins 2024 Automotive News PACE Innovation Partnership Award NORTHVILLE, Mich., April 30, 2024 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, was named a winner of the 2024 Automotive News PACE Innovation Partnership Award for the company’s development of ClimateSense® in collaboration with General Motors. The PACE Innovation Partnership Award recognizes exemplary collaboration between OEM and suppli...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.